Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07059546 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hypersensitivity to Adrenomedullin in Post-Traumatic Headache

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Jul 1, 2025 to Aug 1, 2025
    • Primary completion date: May 2028 to May 1, 2028
    • Study completion date: Dec 2028 to Dec 1, 2028
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Adrenomedullin is a neuropeptide implicated in the pathogenesis of headache. This study investigates whether adrenomedullin induces headache with migraine-like features in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).
Trial Details
NCT Number NCT07059546
Lead Sponsor Danish Headache Center
Conditions
(from sponsor)		 Posttraumatic Headache
Related terms Pain, Post-Traumatic Headache
Enrollment 21 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov